Orilissa

AbbVie puts up fight against Orilissa generics from Sandoz, Teva and others
Endpoints
Mon, 10/31/22 - 04:22 pm
AbbVie
Orilissa
generics
Sandoz
Teva Pharmaceuticals
endometriosis
Myovant Squares Off with AbbVie On Endometriosis Treatment
Motley Fool
Sun, 04/26/20 - 01:49 pm
Myovant Sciences
AbbVie
endometriosis
Relugolix
Orilissa
clinical trials
2 Things Investors Are Missing About AbbVie
Motley Fool
Sun, 03/17/19 - 01:29 pm
AbbVie
ABBV-599
Humira
risankizumab
upadacatinib
Imbruvica
Venclexta
Orilissa
Why Abbvie Is Down 5% in 2018 So Far
Motley Fool
Sat, 11/17/18 - 12:44 pm
AbbVie
Imbruvica
Humira
Orilissa
AbbVie's Orilissa makes its uterine fibroids case with double phase 3 win
Fierce Pharma
Thu, 11/15/18 - 11:39 pm
AbbVie
Orilissa
FDA
uterine fibroids
Neurocrine
AbbVie's new endometriosis drug to cost $10K per year
Biopharma Dive
Tue, 07/24/18 - 11:27 pm
FDA
AbbVie
endometriosis
Orilissa
drug pricing
AbbVie wins FDA approval for oral treatment for endometriosis pain
Marketwatch
Tue, 07/24/18 - 10:21 am
AbbVie
endometriosis
Orilissa